首页> 外文期刊>Neuro-Oncology >Endoplasmic reticulum stress-inducing drugs sensitize glioma cells to temozolomide through downregulation of MGMT, MPG, and Rad51
【24h】

Endoplasmic reticulum stress-inducing drugs sensitize glioma cells to temozolomide through downregulation of MGMT, MPG, and Rad51

机译:内质网应激诱导药物通过下调MGMT,MPG和Rad51使胶质瘤细胞对替莫唑胺敏感

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Endoplasmic reticulum (ER) stress results from protein misfolding imbalance and has been postulated as a therapeutic strategy. ER stress activates the unfolded protein response which leads to a complex cellular response, including the upregulation of aberrant protein degradation in the ER, with the goal of resolving that stress. O-6-methylguanine DNA methyltransferase (MGMT), N-methylpurine DNA glycosylase (MPG), and Rad51 are DNA damage repair proteins that mediate resistance to temozolomide in glioblastoma. In this work we sought to evaluate whether ER stress-inducing drugs were able to downmodulate DNA damage repair proteins and become candidates to combine with temozolomide.
机译:内质网(ER)应力是由蛋白质错误折叠失衡引起的,被认为是一种治疗策略。内质网应激激活了展开的蛋白质反应,从而导致复杂的细胞反应,包括上调内质网中异常蛋白质降解的目的,目的是解决这种压力。 O-6-甲基鸟嘌呤DNA甲基转移酶(MGMT),N-甲基嘌呤DNA糖基化酶(MPG)和Rad51是介导胶质母细胞瘤中替莫唑胺抗性的DNA损伤修复蛋白。在这项工作中,我们试图评估诱导内质网应激的药物是否能够下调DNA损伤修复蛋白并成为与替莫唑胺联用的候选药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号